학술논문
Neoadjuvant Chemotherapy with Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer: Results after a Median Follow-Up of over 4 Years.
Document Type
Article
Author
Source
Breast Care; Oct2016, Vol. 11 Issue 5, p323-327, 5p, 1 Diagram, 2 Charts, 3 Graphs
Subject
Language
ISSN
16613791
Abstract
Copyright of Breast Care is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)